Satellite Symposia Registration

This symposium will present a comprehensive, updated approach to fibromyalgia, from the most current research into pathophysiology to cutting-edge research on diagnosis and treatment options. Participants will be introduced to state-of-the-art research into the “orchestra of central nervous system pathophysiology” gleaned from numerous domains of investigation (eg, genetics, neuroimaging, sleep polysomnography). Fibromyalgia patients form a heterogeneous group with myriad presentations. The wide range of symptoms and overlap with other illnesses can make fibromyalgia extremely difficult to diagnose. The symposium will enable participants to hone their diagnostic skills, with particular focus on the differential diagnosis. An algorithm for pharmacologic therapy utilizing the “triangle” concept will enable participants to select and sequence pharmacologic therapies to address pain, insomnia, and depression. Nonpharmacologic interventions are also needed to address psychosocial aspects of the illness and to augment pharmacologic therapies for physical issues. Approaches for selecting and sequencing these interventions will also be presented. Because of the multifaceted nature of the disease and its far-reaching medical and psychosocial manifestations, multidisciplinary collaboration is critical to ensure continuity of care through comprehensive treatment plans. Participants will receive a “Clinical Toolkit” containing assessment tools and patient handouts to facilitate the day-to-day implementation of diagnosis, treatment, and patient education.

Learning Objectives:

• Describe the pathophysiology of fibromyalgia
• Diagnose fibromyalgia using guideline-based physical examination and assessment tools
• Individualize pharmacologic regimens for patients with fibromyalgia, based on each patient's constellation of symptoms—especially pain, depression, and insomnia
• Engage in multidisciplinary collaboration to ensure a comprehensive treatment plan that integrates pharmacologic and nonpharmacologic interventions

Chairperson or Moderator
I. Jon Russell, MD, PhD
Associate Professor, Medicine/Rheumatology
University of Texas Health Science Center
San Antonio, Texas

Confirmed Faculty
Kim Dupree Jones, RNC, PhD, FNP
Associate Professor
School of Nursing Portland Campus
Oregon Health and Science University
Portland, Oregon

Dennis C. Turk, PhD
John and Emma Bonica Professor of Anesthesiology
and Pain Research
University of Washington
Seattle, Washington


Accreditation/Designation of Credit Statements

Veritas Institute for Medical Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Veritas Institute for Medical Education, Inc. designates this educational activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Veritas Institute for Medical Education, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program UPN 0394-000-10-002-L04-P acceptable for 1.5 Contact Hours. Initial release date: May 7, 2010.

This activity has been submitted to New Jersey State Nurses Association for approval to award contact hours. New Jersey State Nurses Association is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s COA.

This program has been reviewed and approved to offer CE credit for psychologists by the American Psychological Association's Office Continuing Education in Psychology (CEP). This program offers 1.5 CE credits for psychologists.  The CEP Office maintains responsibility for the delivery of the program. 

Funding Statement: Supported by an educational grant from Forest Research Institute, Inc., a wholly-owned subsidiary of Forest Laboratories, Inc.